13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13D Filed 2026-05-21 Event 2026-05-07 SEC 0001213900-26-060059 →

Lai Gang → Universe Pharmaceuticals INC UPC

Stake: 13.58% Shares: 3,467 CUSIP: G9442G138 Class: Class A ordinary shares, par value US$0.00001 per share

Item 4 — Purpose of Transaction

Gang Lai serves as Chief Executive Officer and Chairman of the Board of Directors of the Issuer. In such capacities, Gang Lai may engage in communications with the Issuer's Board of Directors, members of management, other shareholders, financial and legal advisers, and other parties regarding the Issuer, including but not limited to the Issuer's operations, governance and control. In addition, in these capacities, he may have influence over the corporate activities of the Issuer, including activities which may relate to items described in subparagraphs (a) through (j) of Item 4 of Schedule 13D. Except as set forth herein, Gang Lai does not have any plans or proposals which relate to, or could result in, any of the matters referred to in paragraphs (a) through (j), inclusive, of the instructions to Item 4 of Schedule 13D. He may, at any time and from time to time, review or reconsider his position and/or change his purpose and/or formulate plans or proposals with respect thereto. Gang Lai acquired the ordinary shares pursuant to the Equity Grant and intends to maintain his holding in the Issuer on a continuing basis. Nevertheless, he may acquire additional shares of the Issuer or sell or otherwise dispose of any or all of the shares that he beneficially owns.

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
9 13D/G filings on this issuer
8 other filings besides this one
Filer Track Record
1 filings by this filer
0 other filings in the data moat
Short Interest · settle 2026-09-30
DTC 1.08
43,865 shares short · -42.2% vs prior

Post-Filing Returns · since 2026-05-07 on UPC

+1 day
0.0%
+5 days
0.0%
+30 days
0.0%
+60 days
0.0%
+90 days
—
+180 days
—

Anchor price 6.32 on closest trading day on/after 2026-05-07. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on Universe Pharmaceuticals INC

FiledFormFilerStakeShares
2026-09-01 SCHEDULE 13G Xie Shan — — view →
2026-09-01 SCHEDULE 13G Li Xuefeng — — view →
2026-09-01 SCHEDULE 13G Lu Shanshan — — view →
2026-09-01 SCHEDULE 13G Tang Chengming — — view →
2026-09-01 SCHEDULE 13G Zheng Chunhua — — view →
2026-09-01 SCHEDULE 13G Yang Lu (nmn) — — view →
2026-09-01 SCHEDULE 13G Chen Xuncheng — — view →
2026-09-01 SCHEDULE 13G Ye Piao — — view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →